Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status

BACKGROUNDS: Mutations in the isocitrate dehydrogenase (IDH)1 gene are favourable prognostic factors in newly diagnosed diffuse gliomas, whereas it remains controversial in the recurrent glioblastoma setting. METHODS: A total of 171 patients with newly diagnosed glioblastoma, either ‘primary’ gliobl...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Jpn J Clin Oncol
Egile Nagusiak: Tabei, Yusuke, Kobayashi, Keiichi, Saito, Kuniaki, Shimizu, Saki, Suzuki, Kaori, Sasaki, Nobuyoshi, Shiokawa, Yoshiaki, Nagane, Motoo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7767982/
https://ncbi.nlm.nih.gov/pubmed/32888020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa162
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak